When radioactive iodine is an option, patients with very large thyroid glands are more likely to choose surgery because surgery removes the gland right away, while radioactive iodine takes months to shrink it—and may not shrink it enough.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether thyroid volume >70g is consistently associated with higher rates of surgery over radioactive iodine across diverse populations, and whether this leads to better or worse clinical outcomes.
A systematic review and meta-analysis of all prospective studies comparing surgery and radioactive iodine in Graves' disease patients with thyroid volumes >70g, pooling rates of treatment selection, time to euthyroidism, recurrence, and patient satisfaction.
Whether assigning patients with large goiters (>70g) to surgery versus radioactive iodine leads to faster symptom relief, better quality of life, or fewer complications.
A multicenter RCT of 300 adults with Graves' disease and thyroid volume >70g (confirmed by ultrasound), randomized to total thyroidectomy or radioactive iodine (15–20 mCi), with primary outcome: time to euthyroidism and secondary outcomes: goiter volume reduction at 6 and 12 months, dysphagia, voice changes, and patient-reported satisfaction.
Whether patients with Graves' disease and thyroid volume >70g who choose surgery versus radioactive iodine have different long-term outcomes in symptom control and recurrence.
A prospective cohort study following 500 adults with Graves' disease and thyroid volume >70g, recording treatment choice (surgery vs RAI), then tracking time to euthyroidism, goiter volume reduction, recurrence, and complications over 5 years.
The current distribution of treatment choices among patients with Graves' disease and thyroid volume >70g in a real-world clinical setting.
A cross-sectional survey of 1,000 adults with Graves' disease and thyroid volume >70g across 15 centers, recording whether they received surgery or radioactive iodine and the stated reasons for their choice.
Rare cases where patients with very large goiters (>150g) experienced incomplete response to radioactive iodine, leading to persistent symptoms and eventual surgery.
A case series of 20 patients with Graves' disease and thyroid volume >150g who received radioactive iodine but required surgery within 12 months due to persistent compressive symptoms or inadequate volume reduction.